IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sunesis Pharmaceuticals Inc

CUSIP: 867328601 | 195 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Noven Financial Group, Inc.41,000
0.0% of portfolio›$23
Hanson & Doremus Investment Management166
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Noven Financial Group, Inc.
41,000$230.0%N/AN/ADenver, CO2016-11-14
Hanson & Doremus Investment Management
166$10.0%CoreVery LowBurlington, VT2016-11-14